Cargando…

Interleukin-10 Is a Promising Marker for Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Receiving Immunotherapy

BACKGROUND: Immune checkpoint inhibitors (ICIs) brought about a major paradigm shift in non-small cell lung cancer (NSCLC) treatment. However, the use of ICIs is related to an unforeseeable pattern of immune-related adverse events (irAEs). Hence, more precise biomarkers are needed to predict the inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haowei, Zhou, Fei, Zhao, Chao, Cheng, Lei, Zhou, Caicun, Qiao, Meng, Li, Xuefei, Chen, Xiaoxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863608/ https://www.ncbi.nlm.nih.gov/pubmed/35222434 http://dx.doi.org/10.3389/fimmu.2022.840313

Ejemplares similares

Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer
por: Qiao, Meng, et al.
Publicado: (2022)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

The Role of Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Wang, Haowei, et al.
Publicado: (2021)

Eosinophil and IFN-γ associated with immune-related adverse events as prognostic markers in patients with non-small cell lung cancer treated with immunotherapy
por: Hu, Wei-Ting, et al.
Publicado: (2023)

Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer
por: Cheng, Lei, et al.
Publicado: (2023)

Immunodiagnosis — the promise of personalized immunotherapy
por: Wang, Renjie, et al.
Publicado: (2023)

Listeria monocytogenes: a promising vector for tumor immunotherapy
por: Ding, Yi-Dan, et al.
Publicado: (2023)

The application of Interleukin-2 family cytokines in tumor immunotherapy research
por: Zhou, Yangyihua, et al.
Publicado: (2023)

Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors
por: Zeng, Li, et al.
Publicado: (2023)

Localized Interleukin-12 for Cancer Immunotherapy
por: Nguyen, Khue G., et al.
Publicado: (2020)

Outcome differences between PD-1/PD-L1 inhibitors-based monotherapy and combination treatments in NSCLC with brain metastases
por: Wang, Haowei, et al.
Publicado: (2023)

Immunotherapy: a promising approach for glioma treatment
por: Yasinjan, Feroza, et al.
Publicado: (2023)

Immunotherapy: A promising novel endometriosis therapy
por: Li, Wenshu, et al.
Publicado: (2023)

Case Report: Abscopal Effect of Microwave Ablation in a Patient With Advanced Squamous NSCLC and Resistance to Immunotherapy
por: Shao, Chuchu, et al.
Publicado: (2021)

Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy
por: Zhou, Xiaogang, et al.
Publicado: (2021)

Dickkopf-1: A Promising Target for Cancer Immunotherapy
por: Chu, Hang Yin, et al.
Publicado: (2021)

Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
por: Roatt, Bruno Mendes, et al.
Publicado: (2014)

Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy
por: Wang, Ding, et al.
Publicado: (2021)

The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
por: Arnaud, Marion, et al.
Publicado: (2021)

The cGAS-STING Pathway: A Promising Immunotherapy Target
por: Ou, Liang, et al.
Publicado: (2021)

The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?
por: Janji, Bassam, et al.
Publicado: (2022)

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies
por: Xu, Jiuhui, et al.
Publicado: (2023)

Epigenetic Changes Associated With Interleukin-10
por: Zheng, Zhonghua, et al.
Publicado: (2020)

Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy
por: Shang, Bingqing, et al.
Publicado: (2022)

Regulation of the Anti-Inflammatory Cytokines Interleukin-4 and Interleukin-10 during Pregnancy
por: Chatterjee, Piyali, et al.
Publicado: (2014)

Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy
por: Jing, Ying, et al.
Publicado: (2022)

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
por: Sun, Haoyu, et al.
Publicado: (2019)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
por: Yu, Lei, et al.
Publicado: (2022)

Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
por: Wurster, Sebastian, et al.
Publicado: (2022)

Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures
por: Shah, Deep, et al.
Publicado: (2023)

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
por: Ai, Huihan, et al.
Publicado: (2023)

Regulation of Adaptive Immunity; The Role of Interleukin-10
por: Ng, T. H. Sky, et al.
Publicado: (2013)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer
por: Zhou, Lin, et al.
Publicado: (2021)

Glucocorticoid-Induced Leucine Zipper: A Promising Marker for Monitoring and Treating Sepsis
por: He, Ya-Jun, et al.
Publicado: (2020)

The Predictive Model Construction for Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy
por: Gao, Weitong, et al.
Publicado: (2023)

BCG and Adverse Events in the Context of Leprosy
por: Richardus, Renate, et al.
Publicado: (2018)

Interleukin-33 in Systemic Sclerosis: Expression and Pathogenesis
por: Li, Liya, et al.
Publicado: (2018)

Gastrointestinal adverse events of immunotherapy
por: Cappello, Giovanni, et al.
Publicado: (2021)

The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations
por: Terry, Lauren V., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ani58ajpl9nuigjtn0nt9bu099